|
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Your complete resource for handling the physical and emotional
effects of breast cancer treatments. At the time of diagnosis,
breast cancer patients are faced with many overwhelming decisions
about possible treatments. Living with Breast Cancer provides you
with an overview of what to expect from testing and treatment,
which cancer specialists you may need to see, and common terms to
use to help communicate your needs to your team. This empathetic
resource full of relatable stories teaches patients and caregivers
how to ask the right questions to get the best possible care. The
authors explain how to minimize the symptoms and side effects of
treatment and outline coping strategies to deal with the stress of
breast cancer treatment, including the changes in your body from
cancer and its therapies. The book helps readers * make sense of
their diagnosis * set goals and prepare for treatment * understand
the different types of therapies, tests, and scans * manage the
symptoms and side effects of treatment, such as nausea, fatigue,
shortness of breath, weight fluctuations, and depression * learn
what medications and lifestyle modifications can help with symptoms
* live and cope with progressive cancer Living with Breast Cancer
is your definitive resource for handling the physical and emotional
effects of breast cancer and treatment.
Volume 37 will provide details on the major chemical constituents
of medicinal plants and their mechanism of action as the anticancer
compounds. This special issue, in addition to the previous volume
(volume 36 of The Enzyme series was on Natural Products and Cancer
Signaling Targets: Isoprenoids, Polyphenols and Flavonoids), will
highlight the significant advance made in the field in elucidating
mechanisms of anticancer effect of the major phytochemicals.
Cancer: Oxidative Stress and Dietary Antioxidants, Second Edition,
covers the science of oxidative stress in cancer and the
potentially therapeutic usage of natural antioxidants in the diet
or food matrix. The processes within the science of oxidative
stress are described in concert with other processes, such as
apoptosis, cell signaling, and receptor-mediated responses. This
approach recognizes that diseases are often multifactorial and that
oxidative stress is a single component. Other sections cover new
organ site tumors-skin and liver cancer, the role of polymorphisms,
cytochrome p450s, COX gene, fatty acids, apoptosis, T cells and
mitochondria, prevention/protection with anthocyanins, esculetin,
nanoparticles, and more. This book is a valuable resource for
cancer researchers, oncologists, nutritionists and other members of
the biomedical field who are interested in enhancing treatment
outcome, improving the quality of life of patients, and developing
new treatments in the fight against cancer.
The book presents a comprehensive and up-to-date overview of
phytochemicals as efficient cancer therapeutics. Over the last few
decades there has been a paradigm shift from conventional cancer
therapeutic approaches to alternative and complementary medicinal
approaches especially using phytoconstituents from natural
products. As such, the book provides an in-depth understanding of
phytochemicals targeting diverse signaling pathways involved in
cancer along with the evaluation of the cancer modulatory effects
of phytochemicals. It also highlights the potential modulatory
effect of single nucleotide polymorphisms (SNPs) on the
cancer-associated cellular pathways and their interactions with the
phytochemicals. Further, it analyzes the drug delivery methods,
bioavailability of active components of botanicals, and toxicity of
phytochemicals. Lastly, the book elucidates the 3D cell culture and
animal models systems to analyze the beneficial effects of
phytochemicals in cancer.
Biological Mechanisms and the Advancing Approaches to Overcoming
Cancer Drug Resistance, Volume 12, discusses new approaches that
are being undertaken to counteract tumor plasticity, understand and
tackle the interactions with the microenvironment, and disrupt the
rewiring of malignant cells or bypass biological mechanism of
resistance by using targeted radionuclide therapies. This book
provides a unique opportunity to the reader to understand the
fundamental causes of drug resistance and how different approaches
are applied. It is a one-stop-shop to understand why it is so
difficult to treat cancer, and why only a very few patients respond
to therapy and a significant portion develop resistance. Despite a
rapid development of more effective anti-cancer drugs and
combination therapies, cancer remains the leading cause of
lethality in the developed world. The main reason for this is the
ability of heterogeneous subpopulations of tumor cells interacting
with constantly evolving tumor microenvironment to resist
elimination and eventually, trigger cancer relapse. In this book,
experts review current concepts explaining molecular and biological
mechanisms of cancer drug resistance and discussing advancing
approaches for overcoming these therapeutic challenges.
With the rapid development of biotechnologies, single-cell
sequencing has become an important tool for understanding the
molecular mechanisms of diseases, defining cellular heterogeneities
and characteristics, and identifying intercellular communications
and single-cell-based biomarkers. Providing a clear overview of the
clinical applications, the book presents state-of-the-art
information on immune cell function, cancer progression, infection,
and inflammation gained from single-cell DNA or RNA sequencing.
Furthermore, it explores the role of target gene methylation in the
pathogenesis of diseases, with a focus on respiratory cancer,
infection and chronic diseases. As such it is a valuable resource
for clinical researchers and physicians, allowing them to refresh
their knowledge and improve early diagnosis and therapy for
patients.
This book comprehensively summarizes the biology, etiology, and
pathology of ovarian cancer and explores the role of deep molecular
and cellular profiling in the advancement of precision medicine.
The initial chapter discusses our current understanding of the
origin, development, progression and tumorigenesis of ovarian
cancer. In turn, the book highlights the development of resistance,
disease occurrence, and poor prognosis that are the hallmarks of
ovarian cancer. The book then reviews the role of deep molecular
and cellular profiling to overcome challenges that are associated
with the treatment of ovarian cancer. It explores the use of
genome-wide association analysis to identify genetic variants for
the evaluation of ovarian carcinoma risk and prognostic prediction.
Lastly, it highlights various diagnostic and prognostic ovarian
cancer biomarkers for the development of molecular-targeted
therapy.
Elsevier now offers a series of derivative works based on the
acclaimed "Meyler s Side Effect of Drugs, 15th Edition." These
individual volumes are grouped by specialty to benefit the
practicing biomedical researcher and/or clinician.
There has been significant progress in the development of targeted
therapy drugs that act specifically on certain cancers, and that
minimize damage to normal cells. Oncologists and cancer researchers
will rely on this volume to determine effective drug treatments.
* The only drug guide that includes clinical case studies and
expert analysis
* "UNIQUE " Features not only anticancer drugs, but also all other
drugs that act upon related organ systems affected by cancer
* Most complete cross referencing of drug-drug interactions
available
* Latest content from the most highly regarded compilation of drug
side effects: "Side Effects of Drugs Annual" serial"
Revealing essential roles of the tumor microenvironment in cancer
progression, this book provides a comprehensive overview of the
latest research on how different signaling pathways are important
in the tumor microenvironment. Multiple signaling pathways are
covered, including Src, Neuregulin, Adenosine, TGF , Androgen, Wnt,
and more. Taken alongside its companion volumes, these books update
us on what we know about various aspects of the tumor
microenvironment as well as future directions. Tumor
Microenvironment: Signaling Pathways - Part B is essential reading
for advanced cell biology and cancer biology students as well as
researchers seeking an update on research in the tumor
microenvironment.
|
You may like...
The Seasons
James Thomson
Hardcover
R2,452
Discovery Miles 24 520
|